UnitedHealth Group Incorporated has successfully issued a series of notes on March 19, 2024, with varying maturity dates ranging from April 15, 2027, to April 15, 2064. The total principal amount offered across all notes is $5.5 billion, with individual offerings ranging from $400 million to $1.75 billion. The notes have been priced close to par, with interest rates between 4.600% and 5.500%. UnitedHealth has secured stable ratings from Moody's, S&P, and Fitch, indicating a strong credit profile. The settlement date for these notes is scheduled for March 21, 2024. The company has outlined specific redemption provisions, including make-whole calls and par calls, depending on the proximity to the maturity date of each note. In the event of a change of control, UnitedHealth is required to offer to repurchase the notes at 101% of the principal amount, plus accrued interest. The offering was managed by a consortium of banks, including BofA Securities, Barclays Capital, and J.P. Morgan, among others.

UnitedHealth Group Incorporated has successfully issued a series of notes on March 19, 2024, with varying maturity dates ranging from April 15, 2027, to April 15, 2064. The total principal amount offered across all notes is $5.5 billion, with individual offerings ranging from $400 million to $1.75 billion. The notes have been priced close to par, with interest rates between 4.600% and 5.500%. UnitedHealth has secured stable ratings from Moody's, S&P, and Fitch, indicating a strong credit profile. The settlement date for these notes is scheduled for March 21, 2024. The company has outlined specific redemption provisions, including make-whole calls and par calls, depending on the proximity to the maturity date of each note. In the event of a change of control, UnitedHealth is required to offer to repurchase the notes at 101% of the principal amount, plus accrued interest. The offering was managed by a consortium of banks, including BofA Securities, Barclays Capital, and J.P. Morgan, among others.